Global health boost as new vaccine SKYTyphoid gains WHO prequalification

SK bioscience and the International Vaccine Institute (IVI) announced today that the typhoid conjugate vaccine developed by SK bioscience with technology transfer from IVI has achieved the World Health Organization prequalification (PQ), which paves the way for public procurement of the vaccine by UN organizations and gives a boost to the global TCV supply.

Words Found at Scene of CEO Killing May Link to a Book. Here’s What That Could Mean.

As the New York City Police Department continues to search for a motive in the murder of United Healthcare CEO Brian Thompson outside a Manhattan

December 6, 2024

Genetic Revelations Pave the Way for the Development of Designer Mushrooms

Australian researchers have analyzed the genetic makeup of over 100 strains of Psilocybe cubensis, a psychoactive mushroom commonly known as the magic mushroom, encompassing both

December 12, 2023

Psyence Biomed Names Albert P. Garcia-Romeu, Ph.D. as Chair of its Newly Created Scientific Advisory Board | Psychedelic Invest

NEW YORK, Dec. 23, 2024 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence Biomed” or the “Company“) today announced that it has entered into definitive agreements for the

March 11, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.